CliffBio
small molecule

TRIAMCINOLONE ACETONIDE

TRIAMCINOLONE ACETONIDE

Loss of exclusivity—loss of exclusivity
CompanyLong Grove →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIAMCINOLONE ACETONIDE
Active ingredientTRIAMCINOLONE ACETONIDE
Strength40MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJanuary 2022
Marketing statusRX

More from Long Grove

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TRIAMCINOLONE ACETONIDE patent cliff — loss of exclusivity — | CliffBio